Programme

11:00 - 14:00

Registration

14:00 - 14:10

Welcome
Marion Delcroix (KU Leuven; University Hospitals Leuven, Belgium),
David Jenkins (Royal Papworth Hospital, Cambridge, UK);
Marcin Kurzyna (CMKP; European Health Centre Otwock, Poland),
Adam Torbicki (Centre of Postgraduate Medical Education; European Health Centre Otwock, Poland),
Pavel Jansa (Charles University & General University Hospital Prague, Czech Republic),
Joanna Pepke-Zaba (Royal Papworth Hospital, Cambridge, UK)

Session 1: Pathophysiology of CTEPH

Chairs: Irene Lang (Medical University of Vienna, Austria),
Michał Mączewski (Centre of Postgraduate Medical Education (CMKP), Poland)

14:10 - 14:20

Definition of CTEPH
Marion Delcroix (KU Leuven; University Hospitals Leuven, Belgium)

14:20 - 14:30

From acute PE to CTEPH
Erik Klok (Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands)

14:30 - 14:40

The role of exercise testing - diagnostic challenges
Luke Howard (Imperial College London, UK)

14:40 - 14:50

Gene expression changes in the right ventricle in CTEPH
Soni Pullamsetti (Justus Liebig University Giessen; Max Planck Institute, Germany) ON-LINE

14:50 - 15:00

Ring finger transcription factor
Hiroto Shimokawahara (Department of Cardiology, NHO Okayama Medical Center, Japan)

15:00 - 15:10

Clonal haematopoiesis
Irene Lang (Medical University of Vienna, Austria)

15:10 - 15:40

Q&A with the panel

15:40 - 16:10

Coffee break

Session 2: Diagnostic challenges

Chairs: Pavel Jansa (Charles University & General University Hospital Prague, Czech Republic),
Christoph Wiedenroth (Kerckhoff Clinic, Bad Nauheim, Germany)

16:10 - 16:20

Is nuclear medicine scan still relevant?
Nick Kim (University of California San Diego, USA)

16:20 - 16:30

CTPA and common traps in interpretation of CTEPH
Nick Screaton (Royal Papworth Hospital, Cambridge, UK)

16:30 - 16:45

Reporting of CTPA results - differences between centres
Vladimir Cerny (Charles University, Faculty of Medicine in Hradec Králové)

16:45 - 16:55

Pulmonary angiography and visualisation of distal vasculature
Christoph Wiedenroth (Kerckhoff Clinic, Bad Nauheim, Germany)

16:55 - 17:05

Impact of AI/new technologies on pulmonary circulation imaging
Olivier Meyrignac (Hôpital Bicêtre AP-HP, France)

17:05 - 17:35

Q&A with the panel

17:35

Closure of day 1

09:00-09:10

Welcome: PERT – a new partner in management of acute pulmonary embolism

Session 3: Treatment paradigms in acute/subacute PE

Chairs: Adam Torbicki (Centre of Postgraduate Medical Education; European Health Centre Otwock, Poland),
Michael M. Madani (University of California San Diego, USA)

09:10-09:20

Pulmonary Embolism Response Team - different models, outcomes
Richard N. Channick (UCLA Medical Center, USA)

09:20-09:30

Catheter-directed treatments - why not thrombolysis?
Piotr Pruszczyk (Medical University of Warsaw, Poland)

09:30-09:40

CDT in real-life
Marcin Kurzyna (CMKP; European Health Centre Otwock, Poland)

09:40-09:50

Outcomes from recent RCTs - PEERLESS
C. Gerges

09:50-10:00

Outcomes from recent RCTs - HI-PEITHO
Stavros V. Konstantinides (University Medical Center Mainz, Germany)

10:00-10:10

Industry session
Timothy M. Fernandes (University of California San Diego, USA)

10:10-10:20

Polish National Registry - long term outcomes of mechanical thrombectomy
Aleksander Araszkiewicz (Poznan University of Medical Sciences, Poland)

10:20-10:30

Pitfalls and dangers of catheter-directed treatments
Marion Delcroix (KU Leuven; University Hospitals Leuven, Belgium),
Jenny Yang (University of California San Diego, USA)

10:30-11:00

Q&A with the panel

11:00-11:30

Coffee break

Session 4: Management of CTEPH

Chairs: J. Lindner, Hiromi Matsubara (NHO Okayama Medical Center, Japan)

11:30-11:40

Surgical technique
Michael M. Madani (University of California San Diego, USA)

11:40-11:50

Perioperative management
David Jenkins (Royal Papworth Hospital, Cambridge, UK)

11:50-12:00

BPA technique and periprocedural management – insights from the ESC Working Group Consensus Statement
Marcin Kurzyna (CMKP; European Health Centre Otwock, Poland)

12:00-12:10

PH medical therapies and long-term anticoagulation for CTEPH
Marion Delcroix (KU Leuven; University Hospitals Leuven, Belgium)

12:10-12:20

Experiences with a staged approach in high-risk patients
Jean-Noël Andarelli (Hôpital Marie Lannelongue, France)

12:20-12:30

Residual PH after mechanical intervention
Joanna Pepke-Zaba (Royal Papworth Hospital, Cambridge, UK)

12:30-12:40

New treatment strategies in inoperable CTEPH
Xavier Jaïs (Hôpital Bicêtre AP-HP, France)

12:40-13:10

Q&A with the panel

13:10-15:10

Lunch break

Session 5: Key messages from abstracts

Chairs: Adam Torbicki (Centre of Postgraduate Medical Education; European Health Centre Otwock, Poland),
Joanna Pepke-Zaba (Royal Papworth Hospital, Cambridge, UK)

15:10-15:55

Abstract presentations

15:55-16:10

Award presentation

16:10-16:40

Coffee break

Session 6: What we can learn from registries?

Chairs: Aleksander Araszkiewicz (Poznan University of Medical Sciences, Poland),
Xavier Jaïs (Hôpital Bicêtre AP-HP, France)

16:40-16:50

Role of registries and "real world" data in rare and complex disease
Nick H. Kim (University of California San Diego, USA)

16:50-17:00

ICA registry outcomes: Global CTEPH and BPA
Irene Lang (Medical University of Vienna, Austria)

17:00-17:30

National CTEPH registries

Poland – Grzegorz Kopeć (Jagiellonian University, Poland)
Czech Republic – Pavel Jansa (Charles University, Czech Republic)
Spain – Pilar Escribano Subias (Hospital 12 de Octubre, Spain)
Turkey – Bedrettin Yıldızeli – (Marmara University, Turkey)

17:30-17:40

How close is our practice to the ERS/ESC guidelines?
Joanna Pepke-Zaba (Royal Papworth Hospital, Cambridge, UK)

17:40-18:10

Q&A with the panel

18:10

Closure of day 2

09:00-09:10

Welcome: ERN-LUNG – a new partner in CTEPH management

Session 7: Learning CTEPH through interesting cases

Chairs: Iveta Simkova (Head-Cardiology and Angiology Dept, Faculty of Medicine, Slovak Medical University and National CV Institute, Bratislava, Slovakia),
Eckhard Fadel (Medical University of Vienna – Department of Internal Medicine II, Cardiology)

09:10-09:20

Maffucci syndrome and distal CTEPH treated with BPA
Szymon Darocha (CMKP; European Health Centre Otwock, Poland)

09:20-09:30

Residual PH
Bennet Steudel (Kerckhoff-Klinik, Bad Nauheim, Germany)

09:30-09:40

Unexpected finding of chronic CTEPH deposits at surgical embolectomy due to acute PE
Dariusz Zielinski (Medicover Hospital in Warsaw, Cardiac Surgery Clinic, Poland)

09:40-09:50

Catastrophic APL syndrome
Marcel Ourada (General University Hospital in Prague – VFN)

09:50-10:00

Combination of intravascular lead extraction and epicardial lead placement during PEA
Jenny Yang (University of California San Diego, USA)

10:00-10:10

Bronchial embolization to reduce competitive flow
Jean-Noël Andarelli (Hôpital Marie Lannelongue, France)

10:10-10:40

Round table discussion of CTEPH experts related to presented cases

10:40-11:10

Coffee break

Session 8: Future of CTEPH landscape

Chairs: Marcin Kurzyna (CMKP; European Health Centre Otwock, Poland),
David Jenkins (Royal Papworth Hospital, Cambridge, UK)

11:10-11:20

Geographical differences in CTEPH management - what could we learn?
Michael M. Madani (University of California San Diego, USA)

11:20-11:30

Importance of centre experience
Tom Verbelen (KU Leuven; University Hospitals Leuven, Belgium)

11:30-11:40

Hot topic - training of surgeons
Choo Ng (Papworth Hospital NHS Trust, Cambridge, UK)

11:40-11:50

Hot topic - training of BPA operators
Hiromi Matsubara (NHO Okayama Medical Center, Japan)

11:50-12:00

Working under challenging conditions
Lubomir Kulyk (Lviv Danylo Halytsky National Medical University)

12:00-12:10

Patients' voice
Luka Pentke (patient, Germany)

12:10-12:40

Q&A with the panel

12:40-12:45

Meeting closure

The ICC agenda will be supplemented by satellite sponsor symposia, a virtual poster session and industry exhibitions.